- Oct 30, 2019
Risk of malignancy ‘markedly’ increased after childhood cancer
Children who received radiation treatment are nearly 10 times more likely to be diagnosed with breast cancer as an adult, according to new research. Read more: https://www1.racgp.org.au/newsgp/clinical/risk-of-future-malignancy-markedly-increased-after
- Oct 21, 2019
Exercise capacity may affect cognitive health of survivors of childhood leukemia
A new study found a link between reduced exercise capacity and neurocognitive problems in survivors of acute lymphoblastic leukemia (ALL), the most common childhood cancer. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society. Read more: https://www.eurekalert.org/pub_releases/2019-10/w-ecm101619.php
- Oct 15, 2019
The U.S. Is Running Out Of A Critical Childhood Cancer Drug And There Is No Suitable Replacement.
The U.S. is experiencing a critical shortage of a drug called vincristine, used to treat several types of childhood cancer including leukemias and lymphomas after one of the only two U.S. manufacturers, Teva Pharmaceutical decided to discontinue production in July. Read more: https://www.forbes.com/sites/victoriaforster/2019/10/15/the-us-is-running-out-of-a-critical-childhood-cancer-drug-and-there-is-no-suitable-replacement/#475122663c97
- Oct 4, 2019
ICR forms collaboration with AI drug discovery company to develop new possible treatments in rare ch
Scientists at The Institute of Cancer Research, London, are working with Healx, a biotech company specialising in artificial intelligence (AI) to discover new possible ways of treating diffuse intrinsic pontine glioma (DIPG), an essentially untreatable brain cancer in children. Read more: https://www.icr.ac.uk/news-archive/icr-forms-collaboration-with-ai-drug-discovery-company-to-develop-new-possible-treatments-in-rare-childhood-cancer-dipg